Products Overview

China Pharmaceuticals, Inc., CFMI, is a modern hi-tech pharmaceutical corporation integrating traditional Chinese medicines and western medicines. The company combines manufacturing, sales, research and development. The product categories include high-volume and low-volume injections, tablets, capsules, granules, medicinal herbs and teas, syrups, oral solutions, and tinctures. The product line consists of 131 varieties and 11 dosage forms. The company’s medicines are designed to treat nearly every form of common disease and indications from the common cold to Diabetes. All of the company’s products and active pharmaceutical ingredients have the SFDA’s (State Food and Drug Administration) approval. The Chinese government agency, SFDA, is analogous to the Food and Drug Administration (“FDA”) in the United States. Unlike the FDA, however, the SFDA provides intellectual property and competitive protection to certain classes of approved drugs.

We rely on patent, trademark, and trade secret law, as well as confidentiality and license agreements, to protect our proprietary rights. Our numerous Trademark Registration Certificates distinguish our products from those of our competitors. We continue to develop new products in-house as well as through arrangements with several research institutes.

• 132 Products
• 12 Brands
• 11 Dosage Forms
• 111 Prescription Drugs Representing 84% of sales
• 21 OTC Drugs Representing 16% of sales
• 96 Western Drugs Representing 62% of sales
• 36 TCM Drugs Representing 38% of sales
• 3 New TCM Drugs under SFDA Review